Physician
Hematology
Dr. Christoph Heuck, MD
|
|
Give Review
Christoph Heuck practices Hematology. He researched medicine at Albert Einstein College of Medicine. Christoph Heuck, MD has written publications. He has 25 publications published with PubMed. The lastest paper is: 'Monoclonal antibody therapy in multiple myeloma: where do we stand and where are we going?' Christoph Heuck is registered with Medicare.
Publications
- Monoclonal antibody therapy in multiple Myeloma: where do we stand and where are we going?
- The clinical value of molecular subtyping multiple Myeloma using gene expression profiling.
- A common genetic variant in 19q13·3 is associated with outcome of multiple Myeloma patients treated with Total Therapy 2 and 3.
- The flow cytometry-defined light chain cytoplasmic immunoglobulin index and an associated 12-gene expression signature are independent prognostic factors in multiple m...
- Five gene probes carry most of the discriminatory power of the 70-gene risk model in multiple Myeloma.
- Artesunate overcomes drug resistance in multiple Myeloma by inducing mitochondrial stress and non-caspase apoptosis.
- In multiple Myeloma, 14q32 translocations are nonrandom chromosomal fusions driving high expression levels of the respective partner genes.
- Serial exome analysis of disease progression in premalignant gammopathies.
- Jumping translocations of 1q12 in multiple Myeloma: a novel mechanism for deletion of 17p in cytogenetically defined high-risk disease.
- Patterns of Central Nervous System Involvement in Relapsed and Refractory Multiple Myeloma.
- Hematopoietic progenitor cell collection after autologous transplant for multiple Myeloma: low platelet count predicts for poor collection and sole use of resulting gr...
- Metronomic therapy is an effective salvage treatment for heavily pretreated relapsed/refractory multiple Myeloma.
- Risk Factors for MDS and Acute Leukemia Following Total Therapy 2 and 3 for Multiple Myeloma.
- Myeloma Is Characterized by Stage-Specific Alterations in DNA Methylation That Occur Early during Myelomagenesis.
- Pharmacogenomics of bortezomib test-dosing identifies hyperexpression of proteasome genes, especially PSMD4, as novel high-risk feature in Myeloma treated with Total T...
- DNA methylation alterations in multiple Myeloma as a model for epigenetic changes in cancer.
- Nephrocutaneous bypass in ureteral obstruction.
- Translating a gene expression signature for multiple Myeloma prognosis into a robust high-throughput assay for clinical use.
- Characterization of the molecular mechanism of the bone-anabolic activity of carfilzomib in multiple Myeloma.
- mTOR-inhibition in metastatic renal cell carcinoma. Focus on temsirolimus: a review.
- Does a new ultrasound probe change the complication rates of transrectal ultrasound-guided needle biopsies of the prostate?
- The use of molecular-based risk stratification and pharmacogenomics for outcome prediction and personalized therapeutic management of multiple Myeloma.
- Idiopathic giant abdominal lymph cyst: a case report.
- Breast pseudotumoral radionecrosis as a late radiation-induced injury: a case report.
Conditions Treated
- Anemia
- Myeloma
- Neutropenia
- Non-Hodgkin's Lymphoma
- View All
Doctors Specialties
- Hematology
Accepted Insurances
Education
-
Albert Einstein College of Medicine -
Humboldt University of Berlin- Charite Faculty of Medicine
Drug Facts
| NPI NUMBER | 1922326651 | |
| NPPES Provider LastName | HEUCK | |
| NPPES Provider FirstName | CHRISTOPH | |
| NPPES Provider ZIPCode | 104672401 | |
| NPPES Provider State | NY | |
| Specialty Description | Hematology/Oncology | |
| Total Claim Count | 60.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1922326651 |
| Last Name Of The Provider | HEUCK |
| First Name Of The Provider | CHRISTOPH |
| View All |
Similar Doctors
|
|
Dr. Chun F. Ng, MD |
|
|
Dr. Siraj M. El Jamal, MD |
|
|
Dr. Carolina D. Schinke, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Cristina S. Alencar V, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Zulfiqar Hussain, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Nikolaos Papadantonakis, MD |
|
|
Dr. Yifan Tu, MD |